Procter & Gamble (PG)

Financing Cash Flow

-$6.31B

Quarterly · Period ending: · USD

PG logo

PG Financing Cash Flow

Latest reported-$6.31B
PG Quarterly Cash from Financing (-$379.00M → -$6.31B)
High-resolution chart · PNG

PG financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Procter & Gamble Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
-6,306,000,000
-1,827,000,000
-4,088,000,000
-2,239,000,000
-3,616,000,000
-4,215,000,000
-5,571,000,000
-634,000,000
-2,499,000,000
-4,269,000,000
-6,049,000,000
-2,038,000,000
-3,893,000,000
-1,753,000,000
-2,993,000,000
-3,507,000,000
-4,158,000,000
-4,432,000,000
-2,858,000,000
-3,428,000,000
-3,085,000,000
-5,275,000,000
-6,441,000,000
-6,730,000,000
-3,399,000,000
5,945,000,000
-6,795,000,000
-4,118,000,000
-3,304,000,000
-5,066,000,000
1,032,000,000
-2,656,000,000
-6,861,000,000
-5,638,000,000
-152,000,000
-1,724,000,000
-2,229,000,000
-1,600,000,000
-4,232,000,000
-507,000,000
-3,655,000,000
-1,831,000,000
-1,756,000,000
-1,971,000,000
-4,376,000,000
-2,338,000,000
-1,290,000,000
-5,015,000,000
-2,756,000,000
-1,886,000,000
-1,666,000,000
-971,000,000
-2,675,000,000
-2,330,000,000
-835,000,000
-1,231,000,000
-4,654,000,000
-3,460,000,000
-1,877,000,000
-419,000,000
-2,936,000,000
-3,559,000,000
-1,674,000,000
-1,901,000,000
-3,717,000,000
-3,194,000,000
-7,541,000,000
-2,803,000,000
-3,616,000,000
-4,838,000,000
-627,000,000
-1,540,000,000
-3,189,000,000
-5,241,000,000
-3,053,000,000
-3,644,000,000
-950,000,000
-4,892,000,000
-4,126,000,000
-2,510,000,000
-5,216,000,000
-2,491,000,000
-2,255,000,000
-616,000,000
-1,743,000,000
-1,165,000,000
-460,000,000
-765,000,000
460,000,000
-1,973,000,000
-814,000,000
1,959,000,000
-1,432,000,000
-1,516,000,000
-1,623,000,000
-524,000,000
-1,746,000,000
-1,251,000,000
3,583,000,000
-389,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.